SEC Form 4 · accession 0001144204-16-140339
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James F Oliviero III
Officer — CEO and President
Period of report
Dec 15, 2016
Accepted (ET)
Dec 19, 2016 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK (RESTRICTED)F1,F2 | Dec 15, 2016 | A | 325,000 | $0.00 | A | 1,325,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of restricted stock vest as follows: One-half on December 15, 2018, one-fourth on December 15, 2019 and one-fourth on December 15, 2020.
- F2Represents shares of restricted stock which vest over various time periods.